Next, we used the transgenic ACE2 (K18-hACE2) mouse model, which develops lung infection and a respiratory disease resembling severe COVID-19 [18,19], and has been widely used to evaluate interventions against SARS-CoV-2 infection and disease [15,20,21,22,23,24]. This evidence concerns the gene ACE2 and COVID-19.